New technologies adopted by cardiologists not only improve patient care but expand the role of these physicians ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
The FDA granted Conor Medsystems Inc. full approval to enroll up to 1,700 patients in its heart stent clinical ...
The TAXUS Express2 is a stainless steel stent that uses Paclitaxel and Translute polymer to control the drug release ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Using a closed-cell design, the CYPHER stent delivers sirolimus, a drug that selectively targets and interrupts ...
The advanced alloy of the Driver MX2 and Driver OTW has greater strength and more radiopacity than stainless steel. A ...
Based on the clinically proven MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in ...
Engineered specifically for the carotid artery, Xact’s closed-cell, tight-mesh design allows for a high coverage area ...
A self-expandable stent made of nitinol, the Zilver stent incorporates a Z-stent design with opposing Z-shape ...
The FDA has approved revised labeling for the instructions for use of the CYPHER Sirolimus-eluting Coronary Stent ...
The FDA has approved revised labeling for the instructions for use of the CYPHER Sirolimus-eluting Coronary Stent. The ...
Are drug-eluting stents destined to fail?
In Part 1 of this investigation, the connection of DES and thrombogenicity ...
Give a highly ranked research and teaching facility access to cutting-edge technology, and the results could be death ...
The drug-eluting stent (DES) market is a multibillion dollar business in the U.S. — and it's estimated that over three ...